repligen
Repligen is a leader in bioprocessing, dedicated to advancing the production of biologic drugs for improved human health.
Company facts
- Founded
- 1981
- Headquarters
- United States
- CEO
- Olivier Loeillot
About
Repligen is dedicated to inspiring advances in bioprocessing as a trusted partner in the production of biologic drugs that significantly enhance human health worldwide. The company focuses on providing innovative solutions and technologies that facilitate the development and manufacturing of therapies, ensuring that they meet the high standards required in the biopharmaceutical industry. By working closely with its customers, Repligen aims to streamline the processes involved in bioproduction, making them more efficient and effective. Their products are critical in enhancing the production of biologic medicines, which are essential in treating various health issues faced by patients globally. Through their commitment to research and development, Repligen continuously seeks to advance bioproduction technologies, thus contributing to the betterment of global health and helping to bring new therapies to market faster.